Repurposing Inhaled Ibuprofenate, a Non Steroidal Anti‐Inflammatory Drug, as a Potential Adjuvant Treatment for Pneumonia, CARDS and its Aetiological Agent SARS‐CoV‐2
Abstract In this manuscript, we will describe and highlight the most important potential underlying mechanisms of action of the inhaled sodium ibuprofenate in hypertonic saline formulation‐NaIHS aerosolisable, as a probable adjuvant treatment for moderate and severe pneumonia and coronavirus disease...
Saved in:
Main Authors: | Christian Carlos Zurita‐Lizza (Author), Ignacio Rodriguez‐Sanchez (Author), Pablo Alexis Doreski (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2023-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Potential reversal of pulmonary vasoplegia by inhaled ibuprofenate in COVID‐19 pneumonia
by: Christian Carlos Zurita‐Lizza, et al.
Published: (2022) -
Blocking the action of NLRP3 inflammasome by inhaled ibuprofenate on pulmonary macrophages infected by SARS‐CoV‐2
by: Christian Carlos Zurita‐Lizza, et al.
Published: (2023) -
Repurposing of Plasminogen: An Orphan Medicinal Product Suitable for SARS-CoV-2 Inhalable Therapeutics
by: Anna Maria Piras, et al.
Published: (2020) -
Insights from genomic studies on the role of sex steroids in the aetiology of endometriosis
by: Philippa T K Saunders
Published: (2022) -
Ibuprofen versus steroids: risk and benefit, efficacy and safety
by: M. Giovannini, et al.
Published: (2013)